Pagenax Solution for injection 120 mg/ml
Country: Kenya
Language: English
Source: Pharmacy and Poisons Board
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
brolucizumab
Available from:
Novartis Overseas Investments AG Novartis Overseas Investments AG c/o NVS Kenya
ATC code:
S01LA
INN (International Name):
brolucizumab
Dosage:
Solution for injection 120 mg/ml
Pharmaceutical form:
Solution For Injection
Administration route:
INTRAVITREAL
Manufactured by:
Novartis Pharma Stein AG Schaffhauserstrasse CH-4332
Therapeutic area:
Ocularvascular disorderagents:
Product summary:
Shelf life: 24 months; Description: Sterile, clear to slightly opalescent, colorless
Authorization status:
Registered - Valid
